LIXT
Lixte Biotechnology Holdings, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Lixte Biotechnology (LIXT) Stock: Buy, Sell, or Hold?
$7.21
-0.46 (-6.00%)
âŧ
5d:
+8.42%
30d:
+2.41%
90d:
+135.24%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (60%)
Quality Score
45/100
Position
FAIR
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$5.50 / $7.50
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: LIXT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When LIXT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: LIXT is currently trading at $7.21, which is considered fair based on recent price action.
Technical Outlook: Technically, LIXT is in a strong uptrend. Immediate support is located at $5.50, while resistance sits at $7.50. Short-term momentum is weak, with the stock down 6.0% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LIXT is in a strong uptrend. Immediate support is located at $5.50, while resistance sits at $7.50. Short-term momentum is weak, with the stock down 6.0% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
45/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
60.0%
Trading Range & Key Levels
Support Level
$5.50
Resistance Level
$7.50
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BEARISH: Downward momentum (-6.0%)
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Share LIXT Analysis
Share this live LIXT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (LIXT)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jul 6, 2026
Daily AI digest
AI Retail Discussion Summary:
LIXT completed its corporate name change to NOMAD Power Solutions, Inc. and will begin trading under new Nasdaq symbol NMAD.
Key Retail Themes:
Corporate name change
Nasdaq listing
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:44 PM ET
Data refreshes hourly during market hours. Next update: 6:44 PM
Data refreshes hourly during market hours. Next update: 6:44 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LIXT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 69 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 41 HOLD |
|
MDGL
Madrigal PharmaceuticalsâĻ |
STRONG BUY
19 analysts |
$689 | 48 HOLD |
|
IMNM
Immunome Inc |
STRONG BUY
17 analysts |
$35 | 47 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
23 analysts |
$85 | 47 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive LIXT Research Pages
